Collaborative Drug Discovery to Integrate Lilly TuneLab into CDD Vault

Collaborative Drug Discovery has partnered with Eli Lilly and Company to integrate Lilly TuneLab, an AI and machine learning drug discovery platform, into CDD Vault. The collaboration was announced in a press release.

Lilly TuneLab was developed to accelerate biotechnology innovation by giving participating companies access to models trained on decades of Lilly’s proprietary research data. Through this integration, biotech companies using CDD Vault will be able to use select Lilly predictive models within their standard research workflows.

The agreement includes plans to integrate TuneLab within both the core and AI modules of CDD Vault for participating biotech companies. This partnership continues CDD’s focus on supporting web based collaboration in pharmaceutical research.